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The gene, cbl, encoding the species-specific, clavulanate-susceptible, endogenous cephalosporinase was
cloned from Bacteroides uniforinis WAL-7088. The nucleotide sequence was determined, and the cbl structural
gene was found to be 891 nucleotides, with a 48% G+C composition, which is similar to that of the B. uniformis
genome. The cbhi open reading frame encoded an Ambler class A ,B-lactamase polypeptide precursor of 296
amino acid residues with a predicted molecular weight of 33,450. A ,-lactamase-deficient B. uniformis mutant
with increased ,-lactam susceptibility was constructed by insertional inactivation of the chromosomal gene.
This mutant was complemented by plasmids bearing the cblA gene, and the resulting strains were resistant to
cephaloridine and had a P-lactamase that comigrated with the parental j-lactamase on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (30,500 Da) and in isoelectric focusing gels (pl 4.6), confirming a
role for this P-lactamase in resistance.
In Bacteroides species, ,B-lactamases have been known since
the early 1950s (5) and are probably the most important
mechanism of resistance to 1-lactam antibiotics (16). The
enzymes found among members of this genus show a remark-
able degree of diversity and span most of the biochemical
classes described by Bush (2, 3). These include both cephalo-
sporinases and penicillinases, some of which can hydrolyze
cefoxitin or carbapenems. However, the majority ofBacteroides
isolates seem to have at least one P-lactamase with activity that
is species specific, and these are generally found to be cepha-
losporinases, which are inhibited by clavulanate, with pIs of
from 4.5 to 5.5, and with molecular weights in the range of
30,000 (2, 16, 21, 23, 31, 33). In order to understand the
contributions of these indigenous ,B-lactamases to overall
,-lactam resistance in Bacteroides species, we have begun to
characterize the ,-lactamase genes and their regulation. The
endogenous ,B-lactamase from Bacteroides fragilis (CepA) was
recently cloned and sequenced and was found to belong to
Ambler molecular class A (21). Hybridization studies with a
cepA gene probe showed that this f-lactamase gene is specific
for B. fragilis and that there is little or no nucleotide homology
with other Bacteroides species, including Bacteroides uniformis.
Thus, it is of interest to determine the relationship among the
different Bacteroides ,-lactamases.
In this report we describe the cloning and nucleotide
sequence of cblA, which encodes a species-specific P-lactamase
in B. uniformis. The gene was most closely related to other
Bacteroides ,3-lactamase genes, and the protein belonged to
Ambler class A. The cloning was somewhat notable because
high-level 3-lactamase expression was obtained in Escherichia
coli. Most previous reports of the cloning of Bacteroides
antibiotic resistance genes have resulted in low-level or no
expression of the resistance phenotype in E. coli (6, 15, 19-21,
25, 26, 32).
* Corresponding author. Mailing address: Department of Microbi-
ology and Immunology, School of Medicine, East Carolina University,
Greenville, NC 27858. Phone: (919) 816-3127. Fax: (919) 816-3535.
MATERIALS AND METHODS
Bacterial strains and growth. Bacteroides strains were grown
anaerobically in supplemented brain heart infusion broth (19),
and the following antibiotics at the indicated concentrations
were used routinely: clindamycin (Cc), 5 j,g/ml; tetracycline, 5
,ug/ml; rifampin, 20 ,ug/ml; gentamicin, 25 jig/ml; and ampicil-
lin (Ap), 25 jig/ml. B. uniformis BU1001 and V528 are both
rifampin-resistant strains derived from VPI006-1 (24, 34), and
WAL-7088 is a cefoxitin-resistant clinical isolate (35). E. coli
DHS1a (recA hsdR17 lac) was used for all cloning experiments
and library construction. DH5ot was grown aerobically in L
broth (agar) containing Ap (50 ,ug/ml) or spectinomycin (Sp;
40 jig/ml) when appropriate. Susceptibility testing was done by
the standard agar dilution method (14).
Plasmids were transferred in triparental matings from E. coli
donors to Bacteroides recipients by standard filter mating
protocols (29). These used E. coli donor strains containing
RK231 as a conjugation helper plasmid, and the mating plates
were incubated aerobically to enhance the growth of donor
cells. E. coli transformations were done by the method of
Hanahan (7).
DNA manipulations and sequence analysis. Routine DNA
ligations, endonuclease restrictions, plasmid screening, plas-
mid purification, agarose gel electrophoresis, and Southern
hybridizations were done as described previously (1, 13, 21).
The DNA sequence of the 2.8-kb pFD314 cloned insert was
determined in one direction by constructing nested deletions
with exonuclease III (8); this was followed by dideoxy sequenc-
ing (22) by using Sequenase version 2.0 (United States Bio-
chemical Corp., Cleveland, Ohio). The nucleotide sequence of
the opposite DNA strand was elucidated by primer walking by
using sequencing primers deduced from the first DNA strand.
Analysis of the sequence was performed on a VAX computer
by using the GCG analysis software (4), and the GenBank
accession number for the cblA sequence is L08472.
The following plasmids were used or constructed for the
current study. The standard Bacteroides shuttle and cloning
vector pFD288 (Spr CCr) and the suicide vector pFD280.erm
(Spr CCr) have been described previously (19, 26, 29). pFD314
contained the 2.8-kb cblA EcoRI-SmaI fragment cloned into
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TABLE 1. Ampicillin and cephaloridine MICs and ,B-lactamase
activities of B. uniformis strains
MIC (jig/ml)" P-Lactamase activity'
Strain % Activity'
Amp Cep Cep Pen Ncef
BU1001 32 64 0.018 <0.002 0.057 9.8
BU1001flFD483 2 2 d - <0.001
BU1001flFD483 4 8 <0.001
(pFD544)
BU1001flFD483 64 64 0.011 <0.002 0.045 10.7
(pFD548)
WAL-7088 >256 >256 1.796 0.179 4.440 69
a Amp, ampicillin; Cep, cephaloridine.
b Units of activity are micromolar substrate degraded minute-1 milligram of
protein-' for cephaloridine (Cep), benzylpenicillin (Pen), and nitrocefin (Ncef).
c Percent activity of nitrocefin assays containing 1 ,uM potassium clavulanate
relative to that in assays to which no inhibitor was added.
d_d, assays not performed.
the multiple cloning site of pFD288. The suicide plasmid used
for mutagenesis, pFD483, was constructed by insertion of a
560-bp cbL4 HaeIII fragment (base pairs 1071 to 1630) from
cblA into the SmaI site of pFD280.erm. In order to perform
complementation experiments with the cblA insertion mutant,
BU1001flFD483 (Ccr), a tetracycline resistance shuttle vector,
was constructed. This plasmid, pFD544, was similar to pFD288
except that the ermF gene conferring Ccr was replaced by a
2.7-kb SstI fragment bearing the Bacteroides tetQ gene (15).
The 2.8-kb cblA gene fragment was then inserted to make
pFD548, which conferred Spr Apr in E. coli and tetracycline
resistance and Apr in B. uniformis.
jI-Lactamase analysis. Cell extracts for I-lactamase assays
were prepared in 20 mM sodium phosphate buffer (pH 7.0)
with a French pressure cell and were centrifuged at 12,000 x g
for 30 min as described previously (19). Activity was measured
spectrophotometrically with either nitrocefin (482 nm), ben-
zylpenicillin (233 nm), or cephaloridine (260 nm) as the
substrate (17, 19), and the results are given in units in which 1
U equals 1 p,mol of substrate degraded min-1 mg of protein- 1.
Studies testing inhibition with clavulanate were performed by
preincubating cell extracts with 1 ,uM clavulanate for 5 min
prior to the addition of the nitrocefin substrate as described
previously (19). Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) was performed by using a dis-
continuous buffer system (11). The 1-lactamase activity in the
gels was detected after renaturing the proteins in sodium
phosphate buffer by overlaying the gels with nitrocefin-con-
taining agarose (19). The isoelectric focusing gels were run in
polyacrylamide gels with ampholytes (pH 3 to 10) exactly as
described previously (21).
RESULTS AND DISCUSSION
Cloning and nucleotide sequence ofcbl4. B. uniformis WAL-
7088 (Table 1) is a cefoxitin-resistant clinical isolate that uses
a combination of mechanisms for ,B-lactam resistance. Wexler
and Halebian (35) showed that there are changes in the
WAL-7088 penicillin-binding proteins and that the strain
produces a cefoxitin-inactivating activity. During our studies of
WAL-7088, we demonstrated the presence of the cfxA gene,
which encodes a ,-lactamase capable of cefoxitin degradation
(19). In addition, a second ,-lactamase is present in this strain,
and in order to determine its role in ,-lactam resistance, the
gene for this enzyme was cloned and examined. The cloned
gene was obtained from a B. uniformis WAL-7088 EcoRI
library of about 7,300 clones prepared in E. coli DH5a by using
the Spr vector, pFD288. Four Apr colonies were initially
observed after plating the library on medium containing 20 ,ug
ofAp per ml and 40 ,ug of Sp per ml. Restriction endonuclease
analysis of the recombinant plasmids showed that these clones
all share a common 7.8-kb EcoRI fragment.
One clone was chosen for further examination, and subclon-
ing experiments indicated that a 2.8-kb EcoRI-SmaI fragment
was sufficient to encode Apr in E. coli. Subsequent experiments
showed that the Apr phenotype was independent of orientation
of the cloned fragment. This DNA fragment present on
pFD314 was subjected to exonuclease III treatment, and a set
of nested deletions was obtained for DNA sequence determi-
nation. Analysis of the nucleotide sequence revealed three
open reading frames of greater than 400 bp (Fig. 1). Two of the
protein-coding sequences were truncated, but they shared
significant homology with predicted proteins of genes in Gen-
Bank. The deduced amino acid sequence from the open
reading frame designated Env shared 29% identity with the C
terminus of the E. coli EnvD protein, which is involved in the
cell envelope structure (10). The amino acid sequence deduced
from ORF3 was about 31% identical to the AMP nucleosidase
predicted from the E. coli amn gene (12). The open reading
frame encoding the P-lactamase activity is 891 bp and was
designated cblA for chromosomal ,-lactamase (Fig. 2). The
cblA structural gene has a G+C content of 48%, which was
identical to the composition of the entire cloned 2.8-kb frag-
ment and is consistent with the 46 to 48% G+C content of the
B. uniformis species (9). Assignment of the cblA gene was
consistent with analysis of the pFD314 deletion derivatives
(Fig. 1). The strain with A7, which has its 5' end upstream of
the cblA ATG start site, was Apr (MIC, >128 ,ug/ml), but the
strain with A2, which has its 5' end within the predicted cblA
structural gene, was Aps.
The putative CbIA ,B-lactamase precursor would be 296
amino acid residues, with a predicted molecular weight of
33,450. The relationship of CblA to other ,-lactamases was
examined, and the results showed that it is most closely related
to two other Bacteroides P-lactamases, forming a unique group
of Ambler class A P-lactamases (21). The protein has the
greatest homology with the indigenous B. fragilis 3-lactamase,
CepA. There was 43% identity between the aligned protein
sequences of CepA and CblA, and there was 51% identity
between nucleotide sequences of the aligned structural genes
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FIG. 1. Map of the deletions and open reading frames present on
the 2.8-kb EcoRI-SmaI Apr fragment cloned in pFD314 and pFD548.
The relevant open reading frames are indicated by the shaded boxes,
with arrows showing the direction of translation. Some of the deletions
used for phenotypic testing and DNA sequencing are shown below the
map, with a plus or a minus sign indicating the ability or lack of ability
to confer Apr in E. coli, respectively. The thick black bar shows the
cblA HaeIII fragment used as a probe in hybridization experiments and
for insertional inactivation in pFD483. Restriction sites are abbrevi-
ated as follows: Sm, SmaI; Sp, SphI; P, PstI; RV, EcoRV; K, KIpnI; RI,
EcoRI.
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M K A Y F I A I L T L F T C I A T V V R A QQM S E L E N R I D S L
948 TGCTCAATGGCAAGAAAGCCACCGTTGGTATAGCCGTATGACAGACAAAGGAGACATGCTCCGGTATAACGACCATGTACACTTCCCCTTGCTCAGTGT
L N G K K A T V G I A V W T D K G D M L R Y N D H V H I P L L 8 V
.. EC
1048 ATTCAAATTCCATGTGGCACT&GCCGTACTGGACAAGATGGATAAGCAAAGCATCAGTCTGGAC AGCATTGTTTCCATAAAGGCATCCCAAATGCCGCCC
F K F H V A L AXV L D K M D K Q S I S L D S I V S I K A SQ M P P
+-A2
1148 AATACCTACAGCCCCCTCGGAAGAAGTTTCCCGACCAGGATTTCACGATTACGCTTAGGGAACTGATGCAATACAGCATTTCCCAAAGCGACAACAATG
N T Y S P L R K K F P D Q D F T I T L R E L M Q Y S I S Q S D N N A
1248 CCT&CGACATCTTGATAGAATAT[CAGGAGGCATCAAACATATCAATGACTATATCCACCGGTTGAGTATCGACTCCTTCAACCTCTCGGAAACAGAAGA
C D I L I E Y A G G I K H I N D Y I H R L S I D S F N L S E T E D
SphI . .i
1348 CGGCATGCACTCCAGCTTCGAGGCTGTATACCGCAACTGGAGTACTCCTTCCGCTATGGTCCGACTACTGAGAACGGCTGATGAAAAAGAGTTGTTCTCC
G M S S F E A V Y R N W S T P S A M V R L L R T A D E K E L F S
1448
N K E L K D F L W Q T M I D T E T G A N K L K G M L P A K T V V G H
PatI . . . . HaeIII
1548 ACAAGACCGGCTCTTCCGACCGCAATGCCGACGGTATGAAAACTGCAGATAATGATGCCGGCCTCGTTATCCTTCCCGACGGCCGGAAATACTACATTGC
K T G S S D R N A D G M K N D A G L V I L P D G TRK Y Y I A
1648 CGCCTTCGTCATGGACTCATACGAGACGGATGAGGACAATGCGAACATCATCGCCCGCATATCACGCATGGTATATGATGCGATGAGATGAGAGAGGCAA
A F V M D S Y E T D E D N A N I I A R I S R M V Y D A M R *
PstI . .
1748 GGGGGCTATTGGTAGCTCCTCCTATAAGTTTTGATACTCGGGTATATCCTGCAGAAAAGTATAGCTGTTGTGCTCGTAATCTATGCGGCAACAATAATGC
FIG. 2. Nucleotide sequence showing the region coding for cbl4. The base pair numbering corresponds to that of the GenBank sequence
L08472, which encompasses the entire 2.8-kb fragment shown in Fig. 1. The proposed signal sequence cleavage sites for B. uniformis (BU) or E.
coli (EC) are indicated by vertical arrows, and the putative serine active site residues are in boldface type. The endpoint of the pFD314 deletion,
A2, is shown by the bracket.
for these two peptides. Upstream of the cepA and cblA ATG
start sites there was only 36% identity in the nucleic acid
sequences for a distance of 500 bp. By comparison, CblA
shared just 24% identity with the TEM1 protein and 22%
identity with the Bacillus cereus f-lactamase III amino acid
sequence.
Analysis and expression of cbUi in B. uniformis. The possi-
bility that cblA encoded the indigenous B. uniformnis chromo-
somal 1-lactamase was supported by Southern hybridization
experiments by using an internal cblA fragment (Fig. 1) as the
probe. These results showed that there was a homologous
fragment present in EcoRI digests of B. uniformis WAL-7088,
V528, and BU1001, but only a very weak hybridization signal
was observed with the chromosomes of B. fragilis, Bacteroides
ovatus, and Bacteroides vulgatus (27).
Additional evidence for the role of cblA was obtained by
constructing a ,B-lactamase-deficient B. uniformis mutant by
targeted insertional inactivation. The strain chosen for mu-
tagenesis was BU1001, which contained a cephalosporinase
which was inhibited by >50% by 1 ,uM clavulanate (Table 1).
For the experiment, an internal cblA gene fragment (Fig. 1)
was inserted into the suicide vector pFD280.erm, and the
resulting construct, designated pFD483, was then conjugated
into BU1001. The clindamycin-resistant transconjugants ob-
tained from this mating were found to have pFD483 inserted
into the chromosomal copy of cblA (27). This insertion by a
single crossover event was mediated by homologous recombi-
nation, and disruption of the gene resulted in a complete loss
of 3-lactamase activity, as was seen with strain BUlOOlQl
FD483 (Table 1). In addition, there was an 8- to 32-fold
decrease in the MICs of 1-lactam antibiotics for the mutant
BU100lFD483.
13-Lactamase activity could be restored in mutant strains
when plasmids containing the cloned cblA gene were intro-
duced into the mutants. This was shown with pFD548, which
contained the 2.8-kb EcoRI-Smal cblA fragment (from
pFD314) and a tetracycline resistance gene (tetQ) for coun-
terselection. In the mutant BU100WlFD483 containing
pFD548, ,B-lactamase activity was restored to nearly the same
level as that seen in the parent strain, BU1001. This activity
was cephalosporinase in nature and was inhibited by clavu-
lanate, like BU1001 was (Table 1). In contrast, BU1001fl
FD483 cells containing only the vector pFD544 displayed no
detectable P-lactamase activity, and there was no increase in
the P-lactam MICs for those cells (Table 1). Experiments
similar to these were attempted with the strain B. uniformis
WAL-7088. However, repeated attempts to transfer any plas-
mids into this strain via conjugation were unsuccessful. The
underlying reasons for this inability to function as a recipient
strain were not investigated.
Isoelectric focusing and SDS-PAGE were used to character-
ize the cloned cblA gene product. On the basis of staining of
SDS-polyacrylamide gels for nitrocefin activity, strain WAL-
7088 had two ,B-lactamases (Fig. 3). One was 38,000 to 40,000
Da and corresponded to CfxA, the ,B-lactamase with cefoxitin-
degrading activity (19). The second nitrocefin-reactive protein
was about 30,500 Da and comigrated with the single band of a
protein with P-lactamase activity present in BU1001 cells.
Consistent with the idea that cblA encoded the indigenous B.
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FIG. 3. SDS-polyacrylamide gel of crude cell extracts stained for
,B-lactamase activity by overlaying with nitrocefin as described in the
text. Lanes: 1, BU1001 (235 p.g); 2, BU1001flFD483 (409 ,ug); 3,
BU1001flFD483(pFD544) (319 jig); 4, BU1001flFD483(pFD548)(317 ,ug); 5, WAL-7088 (212 p,g); 6, prestained standards. Estimated
molecular weights of the dye-containing proteins: lysozyme (18,500),
trypsin inhibitor (27,500), carbonic anhydrase (32,500), ovalbumin
(49,500), bovine serum albumin (80,000), and phosphorylase B
(106,000).
no detectable band of a protein with 1-lactamase activity, but
a mutant containing the cloned gene (pFD548) displayed a
protein with ,B-lactamase activity that comigrated with the
band of a protein from BU1001 with ,3-lactamase activity. No
such band was observed in gels of BU1001flFD483 cells
containing just the vector pFD544 (Fig. 3; compare lanes 1 to
4). Isoelectric focusing experiments yielded results consistent
with those of SDS-PAGE. Examination of BU1001 revealed
one major band with a pl of 4.6 and minor bands at pIs 4.8 and
5.2. Other strains of B. uniformis also have ,-lactamases with
pIs in the same range (18), and one study of six strains with a
"normal" substrate profile showed that all had a major band
with a pl of 4.5 (33). Interestingly, all three bands of proteins
with ,B-lactamase activity were missing from the mutant
BU1001flFD483 but were restored in mutants containing
pFD548 (27). This suggests that there might be some hetero-
geneity in the processing of the ,-lactamase precursor or some
proteolytic degradation of the enzyme upon storage. Results
obtained with cell-free extracts of strain WAL-7088 showed
that there was consistently one major band of a protein with
,-lactamase activity that comigrated with the band of a protein
from BU1001 with 3-lactamase activity (pI 4.6). In addition, a
second minor band of a 3-lactamase with a pl of 4.8 was
observed. We have shown previously that the CfxA P-lacta-
mase in B. vulgatus CLA341 does not focus well (19). Similarly,
results with B. uniformis WAL-7088 demonstrated a large
nitrocefin-reactive region in the alkaline region of the gel, but
this did not form a definitive band of activity.
Expression of cbUA in E. coli. A variety of studies have
demonstrated the differential expression or the lack of expres-
sion of Bacteroides antibiotic resistance genes in E. coli (6, 20,
28, 30). The ability of E. coli to express cblA was not the result
of a mutation, as was shown previously for the Bacteroides
metallo-13-lactamase CcrA (20). This possibility was excluded
by transformation experiments with pFD314 in which the
antibiotic selection for transformants was either Spr or Apr.
The results showed that transformation frequencies were
essentially identical regardless of the antibiotic used for selec-
tion. If a mutation was required for expression of the B.
uniformis cblA gene, the Apr transformation frequency would
be much lower than that for spr. Thus, expression of cblA in E.
coli must be mediated by a mechanism different from that seen
for ccrA.
In summary, the following evidence supports the idea that
eblA encodes the species-specific endogenous P-lactamase of
B. unifornis. The gene encodes a protein with 3-lactamase
activity that comigrates in SDS-polyacrylamide gels and iso-
electric focusing gels with the enzyme found in several B.
uniformis strains. The enzyme is a cephalosporinase, it is
susceptible to clavulanate, and it has a pI of 4.6, all of which are
characteristics similar to those previously reported for the
low-level, endogenous B. unifornis f-lactamases (Table 1) (18,
31, 33). Hybridization studies showed that cblA is homologous
to DNA fragments in B. uniformis but not other Bacteroides
species. Finally, B. uniformis mutants lacking 1-lactamase were
constructed by using a cbl4 gene fragment to mediate inser-
tional inactivation of the gene.
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